Application Sponsors
ANDA 091189 | MAYNE PHARMA INC | |
Marketing Status
Application Products
001 | TABLET;ORAL | 5MG | 0 | METHAMPHETAMINE HYDROCHLORIDE | METHAMPHETAMINE HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2010-04-21 | |
LABELING; Labeling | SUPPL | 2 | AP | 2016-09-02 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2016-09-02 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2019-11-14 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2019-11-14 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2019-11-14 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 3 |
SUPPL | 2 | Null | 15 |
SUPPL | 3 | Null | 7 |
SUPPL | 4 | Null | 7 |
SUPPL | 5 | Null | 15 |
SUPPL | 6 | Null | 15 |
TE Codes
CDER Filings
MAYNE PHARMA INC
cder:Array
(
[0] => Array
(
[ApplNo] => 91189
[companyName] => MAYNE PHARMA INC
[docInserts] => ["",""]
[products] => [{"drugName":"METHAMPHETAMINE HYDROCHLORIDE","activeIngredients":"METHAMPHETAMINE HYDROCHLORIDE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"METHAMPHETAMINE HYDROCHLORIDE","submission":"METHAMPHETAMINE HYDROCHLORIDE","actionType":"5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)